Study objective: Previous studies have suggested that serum markers of smoo
th muscle destruction have utility in predicting ectopic pregnancy. Our goa
l was to determine whether a novel marker of muscle destruction, smooth mus
cle heavy-chain myosin (SMHC), is elevated in the serum of patients with ec
topic pregnancy.
Methods: We conducted a prospective cohort study, with consecutive enrollme
nt, of all women in the first trimester of pregnancy who presented to our u
rban emergency department with complaints of lower abdominal pain with or w
ithout vaginal bleeding. Patients were excluded if there was a history of r
ecent surgery or major trauma. Means were compared using 2-tailed Student's
t test with P values less than .05 set for significance. Data analysis inc
luded calculation of receiver operating characteristic (ROC), 95% confidenc
e intervals (Cls), and a regression model.
Results: A total of 175 patients were enrolled; ectopic pregnancy was diagn
osed in 29, and 146 had other diagnoses. Patients with ectopic pregnancy ha
d a mean serum SMHC con centration of 2.53 ng/dL (95% CI 1.84 to 3.22), whe
reas those in the non-ectopic pregnancy group had a mean concentration of 1
.41 ng/dL(95% CI 1.23 to 1.60; P<.0001). ROC analysis demonstrated an area
under the curve of 0.72 (95% Cl 0.65 to 0.79). Regression analysis to exami
ne confounders in each group analyzed the effects of race, maternal age, es
timated gestational age, and serum levels of human chorionic gonadotropin b
eta-subunit. Our analysis identified only a positive correlation between es
timated gestational age and SMHC in the non-ectopic pregnancy group.
Conclusion: There is a statistically significant elevation of serum SMHC le
vels in tubal pregnancy, although our data suggest that the assay has limit
ed clinical utility as a lone marker for ectopic pregnancy. Further investi
gation is needed to determine whether the assay has a role as an adjunct in
the evaluation of suspected ectopic pregnancy.